β受体阻滞剂-话题@MedSci

#β受体阻滞剂#

106篇内容 | 4681人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1274920, encodeId=316f12e4920f2, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=黄峻：JNC8不能否认β受体阻滞剂的“中国特色”, objectType=article, longId=28725, objectId=acd428e2528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acd428e2528, replyNumber=0, likeNumber=77, createdTime=2014-01-01, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acd428e2528, moduleTitle=黄峻：JNC8不能否认β受体阻滞剂的“中国特色”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acd428e2528)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274919, encodeId=586512e49196e, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Chest：荟萃分析显示哮喘患者可有选择地使用β受体阻滞剂, objectType=article, longId=28410, objectId=52282841047, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52282841047, replyNumber=0, likeNumber=68, createdTime=2013-12-22, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52282841047, moduleTitle=Chest：荟萃分析显示哮喘患者可有选择地使用β受体阻滞剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52282841047)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274918, encodeId=d2f212e491835, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JAMA Intern Med：行非心脏手术的缺血性心脏病患者应用β受体阻滞剂的疗效, objectType=article, longId=27315, objectId=c61a2e315da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c61a2e315da, replyNumber=0, likeNumber=66, createdTime=2013-12-01, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c61a2e315da, moduleTitle=JAMA Intern Med：行非心脏手术的缺血性心脏病患者应用β受体阻滞剂的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c61a2e315da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274917, encodeId=92b812e4917a5, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=2013 β受体阻滞剂在高血压应用中的专家指导建议, objectType=article, longId=20773, objectId=ee5020e7340, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee5020e7340, replyNumber=0, likeNumber=83, createdTime=2013-07-04, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee5020e7340, moduleTitle=2013 β受体阻滞剂在高血压应用中的专家指导建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee5020e7340)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274916, encodeId=ef4012e4916fd, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=ACE抑制剂与β受体阻滞剂或许可预防化疗导致的心脏毒性, objectType=article, longId=17412, objectId=8f1e1e412de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f1e1e412de, replyNumber=0, likeNumber=68, createdTime=2013-04-17, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f1e1e412de, moduleTitle=ACE抑制剂与β受体阻滞剂或许可预防化疗导致的心脏毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f1e1e412de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274915, encodeId=d88a12e491575, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=对于高血压患者β受体阻滞剂可减少阿尔茨海默型脑损伤, objectType=article, longId=14661, objectId=b1d51466163, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1d51466163, replyNumber=0, likeNumber=101, createdTime=2013-01-23, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1d51466163, moduleTitle=对于高血压患者β受体阻滞剂可减少阿尔茨海默型脑损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1d51466163)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274914, encodeId=05da12e491449, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=β受体阻滞剂不影响慢性肾病死亡率, objectType=article, longId=13153, objectId=cda1131536b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cda1131536b, replyNumber=0, likeNumber=87, createdTime=2012-12-20, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cda1131536b, moduleTitle=β受体阻滞剂不影响慢性肾病死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cda1131536b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274913, encodeId=80b512e49133c, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=SLEEP：褪黑素可改善高血压患者应用β受体阻滞剂相关失眠, objectType=article, longId=10972, objectId=f43a109e2b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f43a109e2b3, replyNumber=0, likeNumber=86, createdTime=2012-11-18, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f43a109e2b3, moduleTitle=SLEEP：褪黑素可改善高血压患者应用β受体阻滞剂相关失眠, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f43a109e2b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274912, encodeId=089d12e4912d6, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=β受体阻滞剂有待深入研究, objectType=article, longId=7280, objectId=d6a3e280ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6a3e280ee, replyNumber=0, likeNumber=89, createdTime=2012-06-23, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6a3e280ee, moduleTitle=β受体阻滞剂有待深入研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6a3e280ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274911, encodeId=2eeb12e4911c7, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=柯元南:澄清观念,用好β受体阻滞剂, objectType=article, longId=7160, objectId=52d5e16003, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52d5e16003, replyNumber=0, likeNumber=91, createdTime=2012-06-20, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52d5e16003, moduleTitle=柯元南:澄清观念,用好β受体阻滞剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52d5e16003)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274910, encodeId=b50912e4910ff, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Cancer: β受体阻滞剂并不降低结直肠癌风险, objectType=article, longId=6180, objectId=fee36180e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fee36180e0, replyNumber=0, likeNumber=99, createdTime=2012-05-18, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fee36180e0, moduleTitle=Cancer: β受体阻滞剂并不降低结直肠癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fee36180e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274908, encodeId=d75e12e490834, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=儿童患者，如何选择β受体阻滞剂, objectType=article, longId=5918, objectId=e37c59183f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e37c59183f, replyNumber=0, likeNumber=106, createdTime=2012-05-06, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e37c59183f, moduleTitle=儿童患者，如何选择β受体阻滞剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e37c59183f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274909, encodeId=dc8912e4909ea, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=从PURE研究谈β受体阻滞剂对社区冠心病的二级预防, objectType=article, longId=5919, objectId=fa5d5919df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa5d5919df, replyNumber=0, likeNumber=74, createdTime=2012-05-06, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa5d5919df, moduleTitle=从PURE研究谈β受体阻滞剂对社区冠心病的二级预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa5d5919df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274907, encodeId=323712e49073f, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=β受体阻滞剂治疗间歇性跛行合并动脉高血压, objectType=article, longId=2694, objectId=f91e2694e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f91e2694e8, replyNumber=0, likeNumber=93, createdTime=2011-06-12, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f91e2694e8, moduleTitle=β受体阻滞剂治疗间歇性跛行合并动脉高血压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f91e2694e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274906, encodeId=d7f812e490648, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JCO：β受体阻滞剂改善乳腺癌患者RFS而非OS, objectType=article, longId=2624, objectId=5a4826248d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a4826248d, replyNumber=0, likeNumber=51, createdTime=2011-06-05, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a4826248d, moduleTitle=JCO：β受体阻滞剂改善乳腺癌患者RFS而非OS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a4826248d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274905, encodeId=a4fb12e490532, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JCO：β受体阻滞剂普萘洛尔降低乳腺癌死亡率, objectType=article, longId=2622, objectId=2929262208, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2929262208, replyNumber=0, likeNumber=75, createdTime=2011-06-05, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2929262208, moduleTitle=JCO：β受体阻滞剂普萘洛尔降低乳腺癌死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2929262208)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

β受体阻滞剂

2020-05-29

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

黄峻：JNC8不能否认β受体阻滞剂的“中国特色”

2014-01-01

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Chest：荟萃分析显示哮喘患者可有选择地使用β受体阻滞剂

2013-12-22

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JAMA Intern Med：行非心脏手术的缺血性心脏病患者应用β受体阻滞剂的疗效

2013-12-01

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

2013 β受体阻滞剂在高血压应用中的专家指导建议

2013-07-04

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

ACE抑制剂与β受体阻滞剂或许可预防化疗导致的心脏毒性

2013-04-17

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

对于高血压患者β受体阻滞剂可减少阿尔茨海默型脑损伤

2013-01-23

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

β受体阻滞剂不影响慢性肾病死亡率

2012-12-20

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

SLEEP：褪黑素可改善高血压患者应用β受体阻滞剂相关失眠

2012-11-18

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

β受体阻滞剂有待深入研究

2012-06-23

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

柯元南:澄清观念,用好β受体阻滞剂

2012-06-20

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Cancer: β受体阻滞剂并不降低结直肠癌风险

2012-05-18

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

儿童患者，如何选择β受体阻滞剂

2012-05-06

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

从PURE研究谈β受体阻滞剂对社区冠心病的二级预防

2012-05-06

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

β受体阻滞剂治疗间歇性跛行合并动脉高血压

2011-06-12

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JCO：β受体阻滞剂改善乳腺癌患者RFS而非OS

2011-06-05

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JCO：β受体阻滞剂普萘洛尔降低乳腺癌死亡率

2011-06-05

科室
- - 订阅+
  - 更多科室
工具
服务